Upcoming Events

There are no upcoming events available at this time.

Past Events

Jun 9, 2021

Galecto will host a key opinion leader event to discuss the current treatment landscape and unmet clinical need for myelofibrosis, as well as the potential for GB2064, Galecto’s LOXL2 inhibitor that is expected to enter a phase 2 trial in the current quarter.

Mar 30, 2021